Carl Zeiss Meditec takes over glaucoma diagnostics products from OEM partner

Corporate news announcement processed and transmitted by Hugin AS.
The issuer is solely responsible for the content of this
announcement.
----------------------------------------------------------------------
--------------

(Dublin/Calif. / Jena, 6 November 2008) Effective 5 November 2008,
Carl Zeiss Meditec acquires all assets related to the manufacturing
of two glaucoma diagnostic products from its long standing OEM
supplier Welch Allyn, a leading manufacturer of frontline medical
products and solutions. This is set out in an agreement between the
two leading medical technology providers as signed yesterday. The
assets acquired consist mainly of IP and manufacturing rights and
design know-how. Both parties agreed on not disclosing any economic
details of the agreement.

About Carl Zeiss Meditec

Carl Zeiss Meditec AG (ISIN: DE 0005313704) is one of the world's
leading medical technology companies. This market position is based
on over 160 years of experience in optical innovation.

The company has two primary areas of activity: In the field of
ophthalmology Carl Zeiss Meditec offers integrated solutions for
treating the four main eye diseases: vision defects (refraction),
cataracts, glaucoma and retinal disorders.
In the field of neuro and ENT surgery, Carl Zeiss Meditec is the
world's leading provider of surgical microscopes and microsurgical
visualisation solutions for a very broad range of applications, such
as tumor and vascular surgery in the head region and/or spinal
surgery.

Carl Zeiss Meditec's medical technology portfolio is rounded off by
visualisation systems for doctors in private practice and promising
future technologies such as intraoperative radiation therapy, which
allows the targeted treatment of breast cancer and brain cancer
directly during surgery.

Carl Zeiss Meditec AG is based in Jena, Germany, with subsidiaries in
Germany (Carl Zeiss Surgical GmbH, Carl Zeiss Meditec
Vertriebsgesellschaft mbH, Acri.Tec GmbH and Carl Zeiss Medical
Software GmbH), the USA (Carl Zeiss Meditec, Inc., Dublin
California), in Japan (Carl Zeiss Meditec Co., Ltd., Tokyo), Spain
(Carl Zeiss Meditec Iberia S.A., Madrid) and France (Carl Zeiss
Meditec S.A.S, La Rochelle, and Carl Zeiss Meditec France SAS, Le
Pecq).

Contacts Carl Zeiss Meditec AG

Patrick Kofler / Director Investor Relations
P: +49 (0) 36 41 - 2 20 - 1 06
F: +49 (0) 36 41 - 2 20 - 1 17
@: investors@meditec.zeiss.com

Eva Sesselmann / Director Corporate Communications
P: +49 (0) 36 41 - 2 20 - 3 31
F: +49 (0) 36 41 - 2 20 - 1 12
@: e.sesselmann@meditec.zeiss.com

http://www.meditec.zeiss.com

About Welch Allyn
Founded in 1915 and headquartered in Skaneateles Falls, New York
(USA), Welch Allyn is a leading global manufacturer of medical
diagnostic equipment and a complete range of digital and connected
solutions. With over 2,300 employees working in 17 different
countries, Welch Allyn specializes in helping doctors, nurses and
other frontline practitioners across the globe provide the best
patient care by developing innovative products, breakthrough
technologies and cutting-edge solutions that help them see more
patients, detect more conditions, and improve more lives. More
information about Welch Allyn and its complete line of connected
products and solutions may be found at www.welchallyn.com.

Media Contact Welch Allyn:
Jamie Arnold, APR / Public Relations Manager
P: 315.685.4599
@: arnoldj@welchallyn.com
www.welchallyn.com

--- End of Message ---

Carl Zeiss Meditec AG
Goeschwitzer Strasse 51-52 Jena Germany

WKN:
531370; ISIN: DE0005313704; Index: Prime All Share, TECH All Share,
TecDAX;
Listed: Freiverkehr in Bayerische Börse München, Freiverkehr in Börse
Stuttgart,
Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse, Geregelter Markt in
Frankfurter Wertpapierbörse;
Copyright © Hugin AS 2008. All rights reserved.